Article No
AG-MR-C0002-M025
Specifications
| CAS No | 186692-45-5 |
| MW | 354.5 |
| Article No | AG-MR-C0002-M025 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Description | (S)-Roscovitine |
| Supplier | Adipogen Life Sciences |
| Format | Powder |
| Notes | (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound.|Chemical. CAS: 186692-45-5. Formula: C19H26N6O. MW: 354.5. (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound. |
| Molecular Formula | C19H26N6O |
| Alias Names | 6-Benzylamino-2-(S)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine |
| Product Type | Chemicals & Biochemicals |
| Purity | >99% |
| Research area | Cell Death |
| Shipping Information | RT |
| Size | 25 mg |
| Solubility | Soluble in DMSO, ethanol or methanol. |
| Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Storage | -20°C, 4°C |
| Technical Specifications | Chemical. CAS: 186692-45-5. Formula: C19H26N6O. MW: 354.5. (S)-enantiomer of (R)-roscovitine (Prod. No. MR-C0001). Potent selective cyclin-dependent kinase 1 (CDK1) inhibitor. Potential neuroprotectant for stroke. Crosses the blood brain barrier. Inhibits CDK5, consequently blocking hypoxia-induced apoptosis in neurons. Potential anti-inflammatory compound. Potential antidiabetic compound. |
| Product Page Updated | 2024-02-01T08:25:01.492Z |
